Open Access
Open access
Journal of Medicinal Chemistry, volume 58, issue 21, pages 8475-8490

Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes

Grozav Adriana 1
Balacescu Ovidiu 2
Bălăcescu Loredana 2
Cheminel Thomas 3
Neagoe Ioana Berindan 2, 4
Therrien Bruno 3
1
 
Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, Victor Babes Str. 41, RO-400012 Cluj-Napoca, Romania
2
 
Department of Functional Genomics, Proteomics and Experimental Pathology, The Oncology Institute “Prof Dr. Ion Chiricuta”, 34-36 Republicii Str, RO-400015, Cluj-Napoca, Romania
4
 
Research Center of Functional Genomics, Biomedicine and Translational Medicine, “Iuliu Hatieganu″ University of Medicine and Pharmacy, 23 Marinescu Str, RO-400337 Cluj-Napoca, Romania
Publication typeJournal Article
Publication date2015-10-30
Quartile SCImago
Q1
Quartile WOS
Q1
Impact factor7.3
ISSN00222623, 15204804
Drug Discovery
Molecular Medicine
Abstract
Sixteen hydrazinyl-thiazolo arene ruthenium complexes of the general formula [(η(6)-p-cymene)Ru(N,N'-hydrazinyl-thiazolo)Cl]Cl were synthesized. All complexes were tested in vitro for their antiproliferative activity on three tumor cell lines (HeLa, A2780, and A2780cisR) and on a noncancerous cell line (HFL-1). A superior cytotoxic activity of the ruthenium complexes as compared to cisplatin and oxaliplatin, on both cisplatin-sensitive and cisplatin resistant ovarian cancer cells, was observed. In addition, the biological activity of two selected derivatives was evaluated using microarray gene expression assay and ingenuity pathway analysis. p53 signaling was identified as an important pathway modulated by both arene ruthenium compounds. New activated molecules such as FAS, ZMAT3, PRMT2, BBC3/PUMA, and PDCD4, whose overexpressions are correlated with overcoming resistance to cisplatin therapy, were also identified as potential targets. Moreover, the arene ruthenium complexes can be used in association with cisplatin to prevent cisplatin resistance development and synergistically to induce cell death in ovarian cancer cells.

Citations by journals

1
2
3
Polyhedron
Polyhedron, 3, 6.25%
Polyhedron
3 publications, 6.25%
European Journal of Medicinal Chemistry
European Journal of Medicinal Chemistry, 3, 6.25%
European Journal of Medicinal Chemistry
3 publications, 6.25%
Antioxidants
Antioxidants, 2, 4.17%
Antioxidants
2 publications, 4.17%
Journal of Inorganic Biochemistry
Journal of Inorganic Biochemistry, 2, 4.17%
Journal of Inorganic Biochemistry
2 publications, 4.17%
Journal of Organometallic Chemistry
Journal of Organometallic Chemistry, 2, 4.17%
Journal of Organometallic Chemistry
2 publications, 4.17%
Applied Organometallic Chemistry
Applied Organometallic Chemistry, 2, 4.17%
Applied Organometallic Chemistry
2 publications, 4.17%
Chemical Society Reviews
Chemical Society Reviews, 2, 4.17%
Chemical Society Reviews
2 publications, 4.17%
Environmental Chemistry
Environmental Chemistry, 1, 2.08%
Environmental Chemistry
1 publication, 2.08%
Oncotarget
Oncotarget, 1, 2.08%
Oncotarget
1 publication, 2.08%
Materials
Materials, 1, 2.08%
Materials
1 publication, 2.08%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 1, 2.08%
International Journal of Molecular Sciences
1 publication, 2.08%
Cancers
Cancers, 1, 2.08%
Cancers
1 publication, 2.08%
Molecules
Molecules, 1, 2.08%
Molecules
1 publication, 2.08%
Frontiers in Genetics
Frontiers in Genetics, 1, 2.08%
Frontiers in Genetics
1 publication, 2.08%
Seminars in Cancer Biology
Seminars in Cancer Biology, 1, 2.08%
Seminars in Cancer Biology
1 publication, 2.08%
Molecular Aspects of Medicine
Molecular Aspects of Medicine, 1, 2.08%
Molecular Aspects of Medicine
1 publication, 2.08%
Regulatory Toxicology and Pharmacology
Regulatory Toxicology and Pharmacology, 1, 2.08%
Regulatory Toxicology and Pharmacology
1 publication, 2.08%
Arabian Journal of Chemistry
Arabian Journal of Chemistry, 1, 2.08%
Arabian Journal of Chemistry
1 publication, 2.08%
iScience
iScience, 1, 2.08%
iScience
1 publication, 2.08%
Biomaterials
Biomaterials, 1, 2.08%
Biomaterials
1 publication, 2.08%
Journal of Molecular Structure
Journal of Molecular Structure, 1, 2.08%
Journal of Molecular Structure
1 publication, 2.08%
Materials Science and Engineering C
Materials Science and Engineering C, 1, 2.08%
Materials Science and Engineering C
1 publication, 2.08%
Inorganica Chimica Acta
Inorganica Chimica Acta, 1, 2.08%
Inorganica Chimica Acta
1 publication, 2.08%
Journal of Applied Toxicology
Journal of Applied Toxicology, 1, 2.08%
Journal of Applied Toxicology
1 publication, 2.08%
Chemical Record
Chemical Record, 1, 2.08%
Chemical Record
1 publication, 2.08%
Organometallics
Organometallics, 1, 2.08%
Organometallics
1 publication, 2.08%
Molecular Pharmaceutics
Molecular Pharmaceutics, 1, 2.08%
Molecular Pharmaceutics
1 publication, 2.08%
Journal of the American Chemical Society
Journal of the American Chemical Society, 1, 2.08%
Journal of the American Chemical Society
1 publication, 2.08%
Journal of Medicinal Chemistry
Journal of Medicinal Chemistry, 1, 2.08%
Journal of Medicinal Chemistry
1 publication, 2.08%
1
2
3

Citations by publishers

2
4
6
8
10
12
14
16
18
20
Elsevier
Elsevier, 19, 39.58%
Elsevier
19 publications, 39.58%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 6, 12.5%
Multidisciplinary Digital Publishing Institute (MDPI)
6 publications, 12.5%
American Chemical Society (ACS)
American Chemical Society (ACS), 5, 10.42%
American Chemical Society (ACS)
5 publications, 10.42%
Wiley
Wiley, 4, 8.33%
Wiley
4 publications, 8.33%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 4, 8.33%
Royal Society of Chemistry (RSC)
4 publications, 8.33%
Taylor & Francis
Taylor & Francis, 2, 4.17%
Taylor & Francis
2 publications, 4.17%
CSIRO Publishing
CSIRO Publishing, 1, 2.08%
CSIRO Publishing
1 publication, 2.08%
Impact Journals
Impact Journals, 1, 2.08%
Impact Journals
1 publication, 2.08%
Frontiers Media S.A.
Frontiers Media S.A., 1, 2.08%
Frontiers Media S.A.
1 publication, 2.08%
King Saud University
King Saud University, 1, 2.08%
King Saud University
1 publication, 2.08%
Proceedings of the National Academy of Sciences (PNAS)
Proceedings of the National Academy of Sciences (PNAS), 1, 2.08%
Proceedings of the National Academy of Sciences (PNAS)
1 publication, 2.08%
2
4
6
8
10
12
14
16
18
20
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Grozav A. et al. Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes // Journal of Medicinal Chemistry. 2015. Vol. 58. No. 21. pp. 8475-8490.
GOST all authors (up to 50) Copy
Grozav A., Balacescu O., Bălăcescu L., Cheminel T., Neagoe I. B., Therrien B. Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes // Journal of Medicinal Chemistry. 2015. Vol. 58. No. 21. pp. 8475-8490.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1021/acs.jmedchem.5b00855
UR - https://doi.org/10.1021%2Facs.jmedchem.5b00855
TI - Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes
T2 - Journal of Medicinal Chemistry
AU - Grozav, Adriana
AU - Bălăcescu, Loredana
AU - Cheminel, Thomas
AU - Balacescu, Ovidiu
AU - Neagoe, Ioana Berindan
AU - Therrien, Bruno
PY - 2015
DA - 2015/10/30 00:00:00
PB - American Chemical Society (ACS)
SP - 8475-8490
IS - 21
VL - 58
SN - 0022-2623
SN - 1520-4804
ER -
BibTex |
Cite this
BibTex Copy
@article{2015_Grozav,
author = {Adriana Grozav and Loredana Bălăcescu and Thomas Cheminel and Ovidiu Balacescu and Ioana Berindan Neagoe and Bruno Therrien},
title = {Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes},
journal = {Journal of Medicinal Chemistry},
year = {2015},
volume = {58},
publisher = {American Chemical Society (ACS)},
month = {oct},
url = {https://doi.org/10.1021%2Facs.jmedchem.5b00855},
number = {21},
pages = {8475--8490},
doi = {10.1021/acs.jmedchem.5b00855}
}
MLA
Cite this
MLA Copy
Grozav, Adriana, et al. “Synthesis, Anticancer Activity, and Genome Profiling of Thiazolo Arene Ruthenium Complexes.” Journal of Medicinal Chemistry, vol. 58, no. 21, Oct. 2015, pp. 8475-8490. https://doi.org/10.1021%2Facs.jmedchem.5b00855.
Found error?